NEW YORK (GenomeWeb News) – Investigators at the BC Cancer Agency in British Columbia have reeled in an infusion of C$10 million (US$9.5 million) in funding from regional and national partners to fund an effort to use genome sequencing to personalize treatments for patients with lymphoid cancers.

The project at the BC Cancer Agency's Centre for Lymphoid Cancer was funded by Genome BC, the BC Cancer Foundation, Genome Canada, and the Canadian Institute of Health Research, Genome BC said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.